panobinostat and Adrenocortical-Carcinoma

panobinostat has been researched along with Adrenocortical-Carcinoma* in 1 studies

Other Studies

1 other study(ies) available for panobinostat and Adrenocortical-Carcinoma

Article	Year
Long Non-Coding RNA Cancer investigation, 2022, Volume: 40, Issue:3 Adrenocortical carcinoma (ACC) is characterized by poor prognosis and high mortality. The suppression of the long-non-coding RNA Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aged, 80 and over; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Beclin-1; Cell Line, Tumor; Female; Histone Deacetylase Inhibitors; Humans; Male; Middle Aged; Panobinostat; RNA, Long Noncoding; Young Adult	2022

Article

Year

Cancer investigation, 2022, Volume: 40, Issue:3

Adrenocortical carcinoma (ACC) is characterized by poor prognosis and high mortality. The suppression of the long-non-coding RNA

Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aged, 80 and over; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Beclin-1; Cell Line, Tumor; Female; Histone Deacetylase Inhibitors; Humans; Male; Middle Aged; Panobinostat; RNA, Long Noncoding; Young Adult

2022